RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers... Show more
RLX Technology Inc., a leading developer and seller of e-vapor products, maintains dominant positioning in China's regulated closed-system e-vapor market with approximately 53% share as of Q3 2025. Its competitive advantages include over 1,200 patents in atomization technology, such as FEELM ceramic coils for superior flavor and nicotine delivery, and a robust offline distribution network via RELX branded stores and partners. The company's shift toward international diversification, now comprising the majority of revenues, leverages proprietary R&D and compliance expertise to penetrate Asia-Pacific and European markets through franchise models and distributor agreements. Medium-term outlook hinges on sustaining premium branding amid illicit competition in lower-tier Chinese cities and scaling high-margin nicotine-free inhalation products for wellness segments, bolstering resilience in a consolidating industry.
RLX faces several pivotal events that could sway investor sentiment. The Q1 2026 earnings release on May 15, 2026, is anticipated to showcase EPS of $0.031 and revenue around $167 million, with focus on international revenue sustainability and gross margin progression to 30%+. License renewals for manufacturing and retail, valid through mid-2027, underscore regulatory compliance, a key differentiator as enforcement intensifies. Strategic partnerships for market entry and product alignment with local preferences could accelerate overseas growth. However, the April 1, 2026, cancellation of VAT export rebates on nicotine e-cigarettes may elevate costs, pressuring margins and prompting scrutiny in upcoming reports. Analyst actions remain mixed: Citigroup maintained Neutral on March 16, 2026, trimming target to $2.50 from $2.60, while broader consensus eyes $3.00+ averages, signaling moderate optimism if execution persists.
The e-vapor sector's trajectory for RLX is intertwined with China's stringent tobacco monopoly regulations, including flavor bans and excise taxes (36% on e-liquids), which have curtailed illegal products but capped domestic penetration below 2% of the 300 million smoker base. Global harm-reduction trends and low penetration in emerging markets offer tailwinds, amplified by RLX's international pivot amid U.S.-China trade frictions. Macro sensitivities include China's economic slowdown curbing discretionary spending on premium vapes, rising commodity costs for components, and geopolitical tensions impacting exports. Interest rate environments influence consumer credit for lifestyle shifts, while inflation could squeeze margins further post-VAT changes. Evolving tech like AI-optimized supply chains aids cost control, but heightened oversight on nicotine pouches signals a tougher regulatory climate.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying whether a stock, ETF, or other asset is poised to move bullish, bearish, or sideways over the next week or month. Designed to detect developing trends, it evaluates potential breakouts or reversals using advanced pattern recognition and historical data analysis. The engine covers a broad spectrum of tradable instruments, featuring searchable prediction categories, historical performance context, and customizable alerts for timely insights. Traders can leverage it to refine strategies amid volatile markets. Explore the Trend Prediction Engine today to enhance your market edge.
Looking to 2026 and beyond, RLX Technology emphasizes multidimensional growth through international expansion, targeting Southeast Asia, the Middle East, and Europe to double its global footprint. Cost efficiencies from automated production and AI supply chains, alongside margin sustainability via premium pods and nicotine-free innovations, are core drivers. Analysts forecast earnings growth of 14.2% annually and revenue at 23% per annum, with ROE reaching 9.3% in three years, underpinned by $1.19B cash for capital returns like extended buybacks. Long-term themes include regulatory evolution—potentially tighter production quotas and flavor alignments with combustibles—versus opportunities in harm-reduction validation and ESG via recycling initiatives. Competitive threats from state-backed entities loom in China, but RLX's compliance moat and 1,200+ patents position it for market consolidation. Consensus price targets averaging $3.00+ reflect expectations of profitable scaling if macro consumer demand holds.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Industry Tobacco
A.I.dvisor tells us that RLX and XXII have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RLX and XXII's prices will move in lockstep.
| Ticker / NAME | Correlation To RLX | 1D Price Change % | ||
|---|---|---|---|---|
| RLX | 100% | +2.17% | ||
| XXII - RLX | 7% Poorly correlated | -3.34% | ||
| TPB - RLX | 6% Poorly correlated | -8.01% | ||
| UVV - RLX | 4% Poorly correlated | -1.25% | ||
| RYM - RLX | 4% Poorly correlated | -7.15% | ||
| ISPR - RLX | 3% Poorly correlated | -5.56% | ||
More | ||||
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RLX declined for three days, in of 257 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RLX as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for RLX turned negative on June 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Aroon Indicator for RLX entered a downward trend on June 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RLX's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RLX advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .
RLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.980) is normal, around the industry mean (19.433). P/E Ratio (17.109) is within average values for comparable stocks, (19.647). RLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.917). Dividend Yield (0.053) settles around the average of (0.045) among similar stocks. P/S Ratio (3.561) is also within normal values, averaging (2.940).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.